PhD/MPhil/MD Radiobiology and Radiotherapy in Liverpool United Kingdom | University of Liverpool

The University of Liverpool has committed £20 million to acquire the Cancer Research Centre and establish new academic positions in Oncology and Radiobiology, strengthening the existing capabilities of the Department of Molecular and Clinical Cancer Medicine. Radiotherapy serves as a fundamental component of both cancer treatment and departmental research. Our objectives include deepening knowledge about radiation's effects on biological materials and enhancing radiation therapy techniques for better patient outcomes.

Departmental scientific investigations benefit from a rich clinical research environment, where basic research consistently incorporates patient-relevant insights from top clinical specialists and addresses pressing clinical challenges.

With diverse fundamental research focuses, the Department conducts globally recognized cancer biology studies supported by translational connections to world-leading clinical research across multiple major cancer types. It holds a pivotal position in the Cancer Research UK Experimental Cancer Medicine Centre's initiatives, while radiation research leverages comprehensive radiotherapy expertise - including privileged access to Clatterbridge Cancer Centre's proton beam facility.

As a vital cancer treatment approach, radiotherapy research within the Department seeks to advance understanding of radiation-biological material interactions (radiobiology) and refine therapeutic radiation delivery methods. Core investigations into cancer cell radiobiology and responses to various radiation types, including ionizing radiation and proton beams, are uniquely supported by access to Clatterbridge's proton beam facility.